The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global ureteral stents market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 6% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Ureteral stents are thin tubes placed in the ureter to help drain urine from the kidney. Their top portion sits on the kidney and the opposite end curls around the bladder. They are primarily utilized to let urine flow through the blocked ureter, decrease the pain associated with the blockage, allow the kidney to function normally and keep the ureter open. They assist in treating and managing conditions like kidney stones, kidney transplants and urinary incontinence. Besides this, they are also used during the treatment of prostate cancer and tumors across the globe.
The rising incidences of kidney and ureteral stones on account of the increasing number of individuals that smoke and consume alcohol represents one of the key factors driving the ureteral stents market. Ureteral stents play a vital role in the procedure of ureteroscopy and ureterorenoscopy. Moreover, during kidney transplants, they are placed in the body of the patient for a few days until the newly implanted kidney adapts to the body. Apart from this, the growing number of renal transplants and rising concerns related to renal dysfunction have also fueled the need for ureteral stents around the world. Furthermore, technological developments in ureteral stents, including the usage of biodegradable materials, have resulted in efficient and improved outcomes concerning urinary and kidney disorders. Moreover, the key players are focusing on reducing stent migration, ureterovesical reflux and tissue irritation during the procedure, which is anticipated to strengthen the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global ureteral stents market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on product type, material, application and end use.
Breakup by Product Type:
Breakup by Material:
Breakup by Application:
Breakup by End Use:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Allium Medical Solutions Ltd., B. Braun Melsungen AG, Biomerics, Boston Scientific Corporation, Becton, Dickinson and Company, Coloplast Ltd., Cook Group Incorporated, Medline Industries Inc., Merit Medical Systems Inc., Olympus Corporation and Teleflex Incorporated.
|Base Year of the Analysis||2020|
|Segment Coverage||Product Type, Material, Application, End Use, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Allium Medical Solutions Ltd., B. Braun Melsungen AG, Biomerics, Boston Scientific Corporation, Becton, Dickinson and Company, Coloplast Ltd., Cook Group Incorporated, Medline Industries Inc., Merit Medical Systems Inc., Olympus Corporation and Teleflex Incorporated|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at